Skip to main content

Table 3 Gender wise comparison of process outcome measures at final follow up; control vs intervention

From: A randomized control trial of primary care-based management of type 2 diabetes by a pharmacist in Pakistan

Parameters Control Arm [Mean ± SD] Intervention Arm [Mean ± SD] Comparison of Male Participants Comparison of Female Participants
Final follow up, n = 52 Final follow up, n = 83
M = 17 F = 35 M = 26 F = 57 CF vs IF
(p-values)
CF vs IF
(p-values)
HbA1c (%) 9.7 ± 1.4 9.7 ± 1.3 7.9 ± 0.7 7.6 ± 0.9 0.0001** 0.0001**
eABG [mg/dL] 233.2 ± 39.9 231.4 ± 37.7 179.2 ± 21.6 171.4 ± 27.1 0.0001** 0.0001**
SBP [mm/Hg] 137.1 ± 6.4 136.7 ± 7.6 125.8 ± 8.3 123.1 ± 10.5 0.0001** 0.0001**
DBP [mm/Hg] 88.8 ± 3.8 88.7 ± 4.4 85.9 ± 4.7 87.1 ± 5.7 0.077 0.148
Cholesterol [mg/dL] 229.1 ± 78 217 ± 36.5 152.6 ± 27 153.8 ± 25.6 0.0001** 0.0001**
TG [mg/dL] 170.2 ± 47.3 173.4 ± 50 141.2 ± 24.1 143.1 ± 34.7 0.283 0.0001**
HDL-C [mg/dL] 48.3 ± 12.3 49.9 ± 14.8 47.8 ± 7.7 49.4 ± 8 0.210 0.170
LDL-C [mg/dL] 75.6 ± 93.5 85.8 ± 67.3 76.5 ± 25.2 75.7 ± 20.2 0.0001** 0.0001**
VLDL-C [mg/dL] 17 ± 18.5 22.3 ± 18.4 28.3 ± 4.8 28.6 ± 6.9 0.284 0.0002**
SCr [mg/dL] 0.9 ± 0.1 0.9 ± 0.1 0.8 ± 0.2 0.8 ± 0.1 0.0001** 0.0001**
  1. Abbreviation: SD Standard deviation, eABG Estimated average blood glucose, SBP Systolic blood pressure, DBP Diastolic blood pressure, TG Triglycerides, HbA1c Glycated Haemoglobin, HDL-C High Density Lipid-Cholesterol, LDL-C Low Density Lipid-Cholesterol, VLDL-C Very Low Density Lipid-Cholesterol, M Male, F Female, CF Control arm final, IF intervention arm final
  2. p-values; **p < 0.001–0.0001